Clinical Study

The Incidence of Various Antiphospholipid Antibodies, Measured by Commercial-Based Laboratory, with Recurrent Spontenous Abortion and the Impact of Their Profiles on Reproductive Outcome with Active Anticoagulant Therapy

Table 2

Reproductive outcomes of the anticoagulant therapy according to various aPL profiles in RSA patients.

Pregnancy
aPL species and titerEstablisheda ( 𝑛 ) total 81Maintaineda ( 𝑛 ) total 74Aborteda ( 𝑛 ) total 7Success rate (%)  91.4 𝑃 value
(weakly versus strongly)
SpeciesTiter

LA
  weakly32    30    2  93.893.8
  strongly0    0    0  

aβ2GPI  
  weakly1    1    0  100100
  strongly0    0    0  

aCL-IgG  
  weakly6    6    0  100*,  **100
  strongly8    8    0  100

-IgM  
  weakly25    24    1  95.096.00.708
  strongly15    14    1  93.3

aPE-IgG  
  weakly17    15    2  92.088.20.312
  strongly8    8    0  100

-IgM
  weakly12    11    1  94.191.70.506
  strongly5    5    0  100

aPS-IgG
  weakly6    5    1  90.0**83.30.389
  strongly4    4    0  100

-IgM
  weakly28    24    4  88.1*85.70.500
  strongly14    13    1  82.9

aSome patients had multiple positive aPLs.
P value for *was 0.176 and for **was 0.227.